abstract |
The present invention relates to (-)-5- (3-chlorophenyl) -α- (4-chlorophenyl) -α- (1-methyl-1H-imidazol-5-yl) tetrazolo [1,5-a] Quinazolin-7-methanamine and pharmaceutically acceptable addition salts thereof, and in particular the use of such compounds in medicine for the treatment of cancer. |